{"title":"评估暴露于偏钒酸钠的yoelii yoelii疟原虫的基因毒性损伤、活性氧和氮物种的产生情况","authors":"Brenda Casarrubias-Tabarez , Norma Rivera-Fernández , Norberto Alarcón-Herrera , Gabriela Guerrero-Palomo , Marcela Rojas-Lemus , Nelly López-Valdez , Jhony Anacleto-Santos , Adriana Gonzalez-Villalva , Martha Ustarroz-Cano , Teresa I. Fortoul","doi":"10.1016/j.etap.2024.104465","DOIUrl":null,"url":null,"abstract":"<div><p>Malaria represents the greatest global health burden among all parasitic diseases, with drug resistance representing the primary obstacle to control efforts. Sodium metavanadate (NaVO<sub>3</sub>) exhibits antimalarial activity against the Plasmodium <em>yoelii yoelii</em> (<em>Pyy</em>), yet its precise antimalarial mechanism remains elusive. This study aimed to assess the antimalarial potential of NaVO<sub>3</sub>, evaluate its genotoxicity, and determine the production of reactive oxygen and nitrogen species (ROS/RNS) in <em>Pyy.</em> CD-1 mice were infected and divided into two groups: one treated orally with NaVO<sub>3</sub> (10 mg/kg/day for 4 days) and the other untreated. A 50% decrease in parasitemia was observed in treated mice. All experimental days demonstrated DNA damage in exposed parasites, along with an increase in ROS and RNS on the fifth day, suggesting a possible parasitostatic effect. The results indicate that DNA is a target of NaVO<sub>3</sub>, but further studies are necessary to fully elucidate the mechanisms underlying its antimalarial activity.</p></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":null,"pages":null},"PeriodicalIF":4.2000,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of genotoxic damage, production reactive oxygen and nitrogen species in Plasmodium yoelii yoelii exposed to sodium metavanadate\",\"authors\":\"Brenda Casarrubias-Tabarez , Norma Rivera-Fernández , Norberto Alarcón-Herrera , Gabriela Guerrero-Palomo , Marcela Rojas-Lemus , Nelly López-Valdez , Jhony Anacleto-Santos , Adriana Gonzalez-Villalva , Martha Ustarroz-Cano , Teresa I. Fortoul\",\"doi\":\"10.1016/j.etap.2024.104465\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Malaria represents the greatest global health burden among all parasitic diseases, with drug resistance representing the primary obstacle to control efforts. Sodium metavanadate (NaVO<sub>3</sub>) exhibits antimalarial activity against the Plasmodium <em>yoelii yoelii</em> (<em>Pyy</em>), yet its precise antimalarial mechanism remains elusive. This study aimed to assess the antimalarial potential of NaVO<sub>3</sub>, evaluate its genotoxicity, and determine the production of reactive oxygen and nitrogen species (ROS/RNS) in <em>Pyy.</em> CD-1 mice were infected and divided into two groups: one treated orally with NaVO<sub>3</sub> (10 mg/kg/day for 4 days) and the other untreated. A 50% decrease in parasitemia was observed in treated mice. All experimental days demonstrated DNA damage in exposed parasites, along with an increase in ROS and RNS on the fifth day, suggesting a possible parasitostatic effect. The results indicate that DNA is a target of NaVO<sub>3</sub>, but further studies are necessary to fully elucidate the mechanisms underlying its antimalarial activity.</p></div>\",\"PeriodicalId\":11775,\"journal\":{\"name\":\"Environmental toxicology and pharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Environmental toxicology and pharmacology\",\"FirstCategoryId\":\"93\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1382668924001054\",\"RegionNum\":3,\"RegionCategory\":\"环境科学与生态学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENVIRONMENTAL SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668924001054","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
Evaluation of genotoxic damage, production reactive oxygen and nitrogen species in Plasmodium yoelii yoelii exposed to sodium metavanadate
Malaria represents the greatest global health burden among all parasitic diseases, with drug resistance representing the primary obstacle to control efforts. Sodium metavanadate (NaVO3) exhibits antimalarial activity against the Plasmodium yoelii yoelii (Pyy), yet its precise antimalarial mechanism remains elusive. This study aimed to assess the antimalarial potential of NaVO3, evaluate its genotoxicity, and determine the production of reactive oxygen and nitrogen species (ROS/RNS) in Pyy. CD-1 mice were infected and divided into two groups: one treated orally with NaVO3 (10 mg/kg/day for 4 days) and the other untreated. A 50% decrease in parasitemia was observed in treated mice. All experimental days demonstrated DNA damage in exposed parasites, along with an increase in ROS and RNS on the fifth day, suggesting a possible parasitostatic effect. The results indicate that DNA is a target of NaVO3, but further studies are necessary to fully elucidate the mechanisms underlying its antimalarial activity.
期刊介绍：
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
